Covid-19 roundup: Congress reportedly nearing $10B funding deal; Merck and Ridgeback tout new molnupiravir data
Congress is reportedly close to securing new federal funding for Covid-19 vaccines, testing and treatments, but the sum will be significantly lower than the White House’s initial ask.
Legislators are nearing a deal to provide $10 billion in new Covid-19 funding, the AP was among those to report, setting up a possible final approval next week. The total is less than half of President Joe Biden’s request for more than $22 billion in early March, and also lower than a $15.6 billion deal that was scuttled a few weeks ago.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.